Pulmonary Valve-Sparing Surgery in Tetralogy of Fallot: Early Results of Pulmonary Flow Hemodynamics
Özgür Yıldırım1, İsmail Balaban2
1Yeni Yuzyil University Gaziosmanpasa Hospital, Department of Cardiovascular Surgery, Istanbul, Turkey
2Yeni Yuzyil University Gaziosmanpasa Hospital, Department of Pediatric Cardiology, Istanbul, Turkey
Keywords: Tetralogy of fallot, pulmonary subvalvular stenosis, pulmonary valve stenosis
Abstract
Introduction: Tetralogy of Fallot is the most common form of cyanotic congenital heart disease. We aimed to share our experience of pulmonary annulus preserving surgery as the current and increasingly preferred treatment option in this study.
Patients and Methods: In this study, the data of 30 pediatric patients who underwent corrective repair by preserving the pulmonary valve annulus were evaluated retrospectively. Demographic data, angiographic, and echocardiographic findings before and after surgery were recorded.
Results: In our study, 20 (66.7%) patients were male, 10 (33.3%) were female; median age of the patients was 29 months. In the preoperative evaluation, 16 patients had a pulmonary valve with two leaflets (53.3%), and 14 patients had three leaflets (46.7%). McGoon indexes calculated as mean 1.82 ± 0.23 by echocardiography and 2 ± 0.29 by angiography. Pulmonary valve annulus Z-scores were determined as mean -1.8 ± 1.1 echocardiographically and -0.9 ± 1.2 angiographically. Mean right ventricle systolic pressures measured in echocardiographic examination at 1st, 7th, and 14th days after surgery were 42.3 ± 6.5, 38.7 ± 4.9, and 35.8 ± 4.9 mmHg, respectively, and decreasing values were significant statistically. Pulmonary valve pressure gradients measured at postoperative 1st, 7th, and 14th days and found as mean 27.2 ± 5.6, 25.5 ± 6.2, and 24.4 ± 6.2 mmHg, respectively; this decrease was also statistically significant. There was no mortality or significant morbidity during the mean 7.97 ± 3.39 months follow-up period.
Conclusion: Preservation of pulmonary valve during surgery is an effective treatment option in the treatment of tetralogy of Fallot in terms of reducing early and late complications and should become a more prevalent technique.
Ethics committee approval was received for this study from the Istanbul Yeni Yuzyil University Clinical Researchs Ethics Committee (Number: 993, Date: June 09, 2020.
Written informed consent was obtained from patients who participated in this study.
Externally peer-reviewed.
Concept/Design - ÖY; Analysis/Interpretation - ÖY, İB; Data Collection - İB; Writing - ÖY, İB; Critical Revision - ÖY; Final Approval - ÖY; Statistical Analysis - ÖY; Overall Responsibility - ÖY.
The authors declared that there was no conflict of interest during the preparation and publication of this article.
The authors declared that this study has received no financial support.